Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT02783664

Evaluating the Effects of Genetic Testing on Patients' Stress Levels

Conditions: Breast Cancer

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 164
Sponsor: Medical College of Wisconsin

Location: Froedtert Hospital Milwaukee Wisconsin

Summary

This prospective Medical College of Wisconsin Cancer Center study will evaluate stress levels in breast cancer patients undergoing genetic testing. It aims to establish baseline stress levels, evaluate pre- and post-test stress levels at multiple time points, focus on the changes in stress levels for the different resulting subgroups. This will help the clinical staff to provide better care for patients both medically and psychologically through potential interventions to decrease stress.

Eligibility Criteria

Inclusion Criteria: * Females 18 years or older. * Identified as currently diagnosed with breast cancer within the past six months or are classified as being at high risk for developing breast cancer (i.e., they have a family history of cancer that puts them at risk for breast cancer) by the Froedtert Hospital \& Medical College of Wisconsin Cancer Genetics Screening Program. Exclusion Criteria: * Prior genetic testing for breast cancer. * Patient is a referral for genetic testing from an outside hospital system for whom there is no access to outside medical records. * Past medical history of breast cancer (not including a current diagnosis of breast cancer within the past six months). * Current or past history of ovarian cancer. * Known family history of a BRCA1/2 mutation or cancer susceptibility genetic mutation. * Patients who are seen in the day hospital for genetic counseling while they are being administered chemotherapy.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02783664). StuddyBuddy aggregates publicly available trial information.